Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "life-science"

587 News Found

Schneider Electric launches EcoStruxure for life science segment
Sustainability | June 11, 2024

Schneider Electric launches EcoStruxure for life science segment

Accelerating sustainability in Indian pharma industry


Merck to acquire life science company Mirus Bio for US$ 600 million
News | May 23, 2024

Merck to acquire life science company Mirus Bio for US$ 600 million

Acquisition will advance Merck’s integrated offering for viral vector manufacturing


Suven Life Sciences posts Q4 FY24 consolidated loss at Rs. 26.54 Cr
News | May 07, 2024

Suven Life Sciences posts Q4 FY24 consolidated loss at Rs. 26.54 Cr

The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024


RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr
News | May 03, 2024

RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr

The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024


Suven Life Sciences to present phase-2 results on Samelisant at AAN 2024
Diagnostic Center | April 16, 2024

Suven Life Sciences to present phase-2 results on Samelisant at AAN 2024

Global Phase-3 study initiation expected in the second half of 2024


Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences
News | March 28, 2024

Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences

Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%


Merck invests € 300 million in new Life Science production site in South Korea
News | March 21, 2024

Merck invests € 300 million in new Life Science production site in South Korea

New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics


Nirma acquires majority stake in Glenmark Life Sciences
News | March 13, 2024

Nirma acquires majority stake in Glenmark Life Sciences

Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals


RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr
News | February 05, 2024

RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr

RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023